GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Molecure SA (WAR:MOC) » Definitions » Shiller PE Ratio

Molecure (WAR:MOC) Shiller PE Ratio : 83.53 (As of Jun. 22, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Molecure Shiller PE Ratio?

As of today (2024-06-22), Molecure's current share price is zł14.20. Molecure's E10 for the fiscal year that ended in Dec23 was zł0.17. Molecure's Shiller PE Ratio for today is 83.53.

The historical rank and industry rank for Molecure's Shiller PE Ratio or its related term are showing as below:

WAR:MOC' s Shiller PE Ratio Range Over the Past 10 Years
Min: 0   Med: 0   Max: 102.2
Current: 82.35

During the past 10 years, Molecure's highest Shiller PE Ratio was 102.20. The lowest was 0.00. And the median was 0.00.

WAR:MOC's Shiller PE Ratio is ranked worse than
80.52% of 154 companies
in the Biotechnology industry
Industry Median: 30.45 vs WAR:MOC: 82.35

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Molecure's adjusted earnings per share data of for the fiscal year that ended in Dec23 was zł-1.090. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is zł0.17 for the trailing ten years ended in Dec23.

Shiller PE for Stocks: The True Measure of Stock Valuation


Molecure Shiller PE Ratio Historical Data

The historical data trend for Molecure's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Molecure Shiller PE Ratio Chart

Molecure Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 114.71

Molecure Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 114.71 -

Competitive Comparison of Molecure's Shiller PE Ratio

For the Biotechnology subindustry, Molecure's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Molecure's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Molecure's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Molecure's Shiller PE Ratio falls into.



Molecure Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Molecure's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=14.20/0.17
=83.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Molecure's E10 for the fiscal year that ended in Dec23 is calculated as:

For example, Molecure's adjusted earnings per share data for the fiscal year that ended in Dec23 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec23 (Change)*Current CPI (Dec23)
=-1.09/147.7411*147.7411
=-1.090

Current CPI (Dec23) = 147.7411.

Molecure Annual Data

Earnings per Share (Diluted) CPI Adj_EPS
201412 0.000 100.122 0.000
201512 -0.041 99.471 -0.061
201612 -0.240 100.366 -0.353
201712 -0.210 102.564 -0.302
201812 -0.330 103.785 -0.470
201912 -0.310 107.123 -0.428
202012 4.900 109.565 6.607
202112 -0.980 119.088 -1.216
202212 -1.090 139.113 -1.158
202312 -1.090 147.741 -1.090

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Molecure  (WAR:MOC) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Molecure Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Molecure's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Molecure (WAR:MOC) Business Description

Traded in Other Exchanges
N/A
Address
Zwirki i Wigury 101, Warsaw, POL, 02-089
Molecure SA is a biopharmaceutical company engaged in discovering, developing, and commercializing novel therapeutics for neoplastic and inflammatory diseases. The company is focused on discovering and developing molecules with potential to become first-in-class or best-in-class drugs worldwide to treat unmet medical needs.